The BBL condemns, and is totally opposed to, the use of performance enhancing drugs and doping practices in the sport of basketball and fully supports the position of the International Olympic Committee, the World Anti-Doping Agency (WADA), UK Anti Doping (UKAD) and FIBA against the use of banned substances and methods.
An Anti-Doping rule violation shall be considered a breach of the BBL Code of Conduct and of the UK Anti Doping Rules.
The use, possession and/or trafficking of banned substances, methods or the encouragement or counselling to use banned substances, or methods; and/or taking measures to mask the use of banned substances or methods by a participant in tournaments, competitions, events or fixtures over which BBL has jurisdiction is unacceptable and will not be tolerated.
Procedure for Testing
Any player competing in the BBL may be tested. Doping Control Officers (DCOs), authorised by UK Anti-Doping will attend matches at random and unannounced. The DCOs will liaise with the match officials to obtain a copy of the scoresheet. They will draw at random two players from each team (i.e. any player who appears on the scoresheet). This will be done at half-time in the game using tokens that are sealed into envelopes which are then opened at the team benches 5 minutes before the end of the game. Team managers may attend the draw.
These players will be required to undertake doping tests after the match in line with UKAD procedures. Full details on testing procedures and results management are available on the UKAD website.
The World Anti Doping Agency has an extensive website where you can find more information on:
The WADA Code
The new WADA prohibited list
Resources for Players
Therapeutic Use Exemption